MFC-XG Ophthalmic Solution 0.5%+0.4%
MFC-XG Ophthalmic Solution 0.5%+0.4% Uses, Dosage, Side Effects, Food Interaction and all others data.
The antibacterial action of moxifloxacin results from inhibition of the topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA.
| Trade Name | MFC-XG Ophthalmic Solution 0.5%+0.4% |
| Generic | Moxifloxacin Hydrochloride + Xanthan Gum |
| Weight | 0.5%+0.4% |
| Type | Ophthalmic Solution |
| Therapeutic Class | Ophthalmic antibacterial drugs |
| Manufacturer | Nipa Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
This ophthalmic solution is used for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms-
Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumonia, Streptococcus viridans group.
Aerobic Gram-negative microorganisms: Acinetobacter iwoffii, Haemophilus influenza, Haemophilus parainfluenzae.
Pediatric Use: The safety and effectiveness of Moxifloxacin in infants below four months of age was not proven. However, several clinical studies show that the drug may be used safely in children even younger than one month of age.
Geriatric Use: No overall differences in safety and effectiveness have been observed between elderly and younger patients.
Dosage
MFC-XG Ophthalmic Solution 0.5%+0.4% dosage
One drop in the affected eye(s) 2 times daily for 7 days.
Side Effects
The most frequently reported ocular side effects such as ocular discomfort, irritation etc. may occur.
Precaution
Prolonged use may result in overgrowth of non-susceptible organisms, including fungi with other anti-infective.
Interaction
Drug-drug interaction studies have not been conducted with Moxifloxacin Hydrochloride.
Pregnancy & Breastfeeding use
Moxifloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus as there are no adequate and well-documented studies in pregnant women.
Moxifloxacin has not been measured in human milk, although it can be presumed to be excreted in human milk. Caution should be exercised when Moxifloxacin is administered to a breast feeding mother.
Acute Overdose
No information is available on over dose of Moxifloxacin.
Storage Condition
Store in a cool and dry place away from light. Keep out of reach of children. Do not touch the dropper tip to surfaces since this may contaminate the solution. After one month of the first opening do not use the medicine of dropper.
Innovators Monograph
You find simplified version here MFC-XG Ophthalmic Solution 0.5%+0.4%
